Abstract is: Kamlesh Khunti CBE is a British physician who is Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester. His research considers diabetes and public health. During the COVID-19 pandemic, Khunti studied the impact of COVID-19 on people living with diabetes. He served on the Scientific Advisory Group for Emergencies (SAGE). He is the director of the National Institute for Health and Care Research (NIHR) Applied Research Collaboration East Midlands.
| human | Q5 |
| P6178 | Dimensions author ID | 0641072534.04 |
| P2671 | Google Knowledge Graph ID | /g/113sqrdzc |
| P244 | Library of Congress authority ID | no2010083715 |
| P691 | NL CR AUT ID | xx0258606 |
| P496 | ORCID iD | 0000-0003-2343-7099 |
| P2038 | ResearchGate profile ID | Kamlesh-Khunti |
| P214 | VIAF ID | 121254684 |
| P10832 | WorldCat Entities ID | E39PCjwDHbpCQf7td34TvHyRgC |
| P166 | award received | Commander of the Order of the British Empire | Q12201477 |
| P108 | employer | University of Leicester Diabetes Research Centre | Q85960835 |
| P101 | field of work | medicine | Q11190 |
| diabetology | Q1207969 | ||
| angiology | Q539690 | ||
| P735 | given name | Kamlesh | Q6358723 |
| Kamlesh | Q6358723 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | physician | Q39631 |
| researcher | Q1650915 | ||
| diabetologist | Q20756907 | ||
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | male | Q6581097 |
| Q45107669 | 'Educator talk' and patient change: some insights from the DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) randomized controlled trial. |
| Q92384431 | 20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study |
| Q38116101 | A Mediterranean diet improves HbA1c but not fasting blood glucose compared to alternative dietary strategies: a network meta-analysis |
| Q28551210 | A Randomised Controlled Trial to Reduce Sedentary Time in Young Adults at Risk of Type 2 Diabetes Mellitus: Project STAND (Sedentary Time ANd Diabetes) |
| Q90360193 | A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans |
| Q36440969 | A Text-Messaging and Pedometer Program to Promote Physical Activity in People at High Risk of Type 2 Diabetes: The Development of the PROPELS Follow-On Support Program. |
| Q36440704 | A cluster randomized controlled trial of the effectiveness and cost-effectiveness of intermediate care clinics for diabetes (ICCD): study protocol for a randomized controlled trial |
| Q38923629 | A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial |
| Q95444573 | A community-based primary prevention programme for type 2 diabetes mellitus integrating identification and lifestyle intervention for prevention: a cluster randomised controlled trial |
| Q45338174 | A comparison of cost per case detected of screening strategies for Type 2 diabetes and impaired glucose regulation: modelling study |
| Q104078409 | A cost comparison of an enhanced primary care diabetes service and standard care |
| Q36933036 | A cross sectional survey of secondary prevention measures in patients with peripheral arterial disease in primary care |
| Q91751675 | A data-driven, meaningful, easy to interpret, standardised accelerometer outcome variable for global surveillance |
| Q42153024 | A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes |
| Q92288244 | A fitting problem: Standardising shoe fit standards to reduce related diabetic foot ulcers |
| Q33603578 | A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data. |
| Q36119568 | A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People wi |
| Q44197835 | A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial |
| Q90213175 | A randomized, open-label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes |
| Q114153191 | A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney disease |
| Q36428082 | A review of exenatide: optimizing glycemic control and associated cardiovascular risk factors in type 2 diabetes |
| Q95405373 | A school-based intervention (‘Girls Active’) to increase physical activity levels among 11- to 14-year-old girls: cluster RCT |
| Q51403192 | A simple strategy for screening for glucose intolerance, using glycated haemoglobin, in individuals admitted with acute coronary syndrome. |
| Q37979832 | A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity |
| Q58053512 | ACCURACY OF INTRACARDIAC INJECTIONS DETERMINED BY A POST-MORTEM STUDY |
| Q110661815 | Abstract 261: Global Patterns of Comprehensive Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes Mellitus: Insights From the Global DISCOVER Registry |
| Q42694874 | Accelerometer-assessed Physical Activity in Epidemiology: Are Monitors Equivalent? |
| Q40133475 | Accuracy of Posture Allocation Algorithms for Thigh- and Waist-Worn Accelerometers |
| Q30482716 | Accuracy of a 12-lead electrocardiogram in screening patients with suspected heart failure for open access echocardiography: a systematic review and meta-analysis. |
| Q50080314 | Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis |
| Q90954550 | Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes |
| Q91988397 | Activity Intensity, Volume, and Norms: Utility and Interpretation of Accelerometer Metrics |
| Q40536743 | Addition of or switch to insulin therapy in people treated with glucagon-like peptide-1 receptor agonists: A real-world study in 66 583 patients |
| Q37731624 | Addressing barriers to initiation of insulin in patients with type 2 diabetes |
| Q93177664 | Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable |
| Q36825661 | Adipocytokine associations with insulin resistance in british South asians |
| Q96130008 | Adults with early-onset type 2 diabetes (aged 18-39 years) are severely underrepresented in diabetes clinical research trials |
| Q43745249 | Adverse responses and physical activity: secondary analysis of the PREPARE trial |
| Q61774653 | All-cause mortality in relation to glycated haemoglobin in individuals with newly diagnosed type 2 diabetes: a retrospective cohort study |
| Q40657716 | An algorithm to improve diagnostic accuracy in diabetes in computerised problem orientated medical records (POMR) compared with an established algorithm developed in episode orientated records (EOMR). |
| Q45928013 | An investigation into the relationship between sleep-disordered breathing, the metabolic syndrome, cardiovascular risk profiles, and inflammation between South Asians and Caucasians residing in the United Kingdom. |
| Q37965291 | An update on exenatide, a novel therapeutic option for patients with type 2 diabetes. |
| Q104455898 | Analysis of the effectiveness of second oral glucose-lowering therapy in routine clinical practice from the Mediterranean area: A retrospective cohort study |
| Q33704450 | Approaches to the organization of multi-practice audits in primary health care in the UK. |
| Q58053319 | Approval times for a multi-centre diabetes study in UK primary care |
| Q92497385 | Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials |
| Q98192642 | Assessing the cost-effectiveness of SGLT2i in type 2 diabetes mellitus: a comprehensive economic evaluation using clinical trial and real-world evidence |
| Q96351294 | Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A Narrative Review |
| Q108990879 | Association Between Accelerometer-Assessed Physical Activity and Severity of COVID-19 in UK Biobank |
| Q38628192 | Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Meta-analysis |
| Q39548167 | Association Between Lifestyle Factors and the Incidence of Multimorbidity in an Older English Population. |
| Q50069620 | Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification. |
| Q99629019 | Association and relative importance of multiple risk factor control on cardiovascular disease, end-stage renal disease and mortality in people with type 2 diabetes: A population-based retrospective cohort study |
| Q42650050 | Association between polypharmacy and falls in older adults: a longitudinal study from England |
| Q93214143 | Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes |
| Q101573177 | Association of Cardiometabolic Multimorbidity and Depression With Cardiovascular Events in Early-Onset Adult Type 2 Diabetes: A Multiethnic Study in the U.S. |
| Q60955307 | Association of Medication Intensity and Stages of Airflow Limitation With the Risk of Hospitalization or Death in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease |
| Q104794194 | Association of Timing and Balance of Physical Activity and Rest/Sleep With Risk of COVID-19: A UK Biobank Study |
| Q99345924 | Association of Type 2 Diabetes With Cancer: A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People |
| Q60910026 | Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe |
| Q57823326 | Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population |
| Q58053357 | Association of cardiac and non-cardiac chronic disease comorbidity on glycaemic control in a multi-ethnic population with type 1 and type 2 diabetes |
| Q33588053 | Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study |
| Q92520379 | Association of circulating osteocalcin with cardiovascular disease and intermediate cardiovascular phenotypes: systematic review and meta-analysis |
| Q91967458 | Association of depression and anxiety with clinical, sociodemographic, lifestyle and environmental factors in South Asian and white European individuals at high risk of diabetes |
| Q50124919 | Association of features of primary health care with coronary heart disease mortality |
| Q57575157 | Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: A systematic review and meta-analysis |
| Q34460582 | Association of primary care characteristics with variations in mortality rates in England: an observational study |
| Q21134687 | Association of sedentary behaviour with metabolic syndrome: a meta-analysis |
| Q39599269 | Association of sitting time and physical activity with CKD: a cross-sectional study in family practices |
| Q91868538 | Association of smoking and cardiometabolic parameters with albuminuria in people with type 2 diabetes mellitus: a systematic review and meta-analysis |
| Q61774637 | Association of smoking and concomitant metformin use with cardiovascular events and mortality in people newly diagnosed with type 2 diabetes |
| Q36200726 | Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study |
| Q47659856 | Association of walking pace and handgrip strength with all-cause, cardiovascular, and cancer mortality: a UK Biobank observational study |
| Q103837780 | Association of weight loss and weight loss maintenance following diabetes diagnosis by screening and incidence of cardiovascular disease and all-cause mortality: an observational analysis of the ADDITION-Europe trial |
| Q38376071 | Associations Between Anthropometric Measurements and Cardiometabolic Risk Factors in White European and South Asian Adults in the United Kingdom |
| Q103825640 | Associations between physical activity and trimethylamine N-oxide in those at risk of type 2 diabetes |
| Q113285005 | Associations between reductions in routine care delivery and non-COVID-19-related mortality in people with diabetes in England during the COVID-19 pandemic: a population-based parallel cohort study |
| Q47836154 | Associations between sedentary behaviours and cognitive function: cross-sectional and prospective findings from the UK Biobank |
| Q38671967 | Associations of Physical Activity Intensities with Markers of Insulin Sensitivity |
| Q58543986 | Associations of Physical Behaviours and Behavioural Reallocations with Markers of Metabolic Health: A Compositional Data Analysis |
| Q60753935 | Associations of Sedentary Time with Fat Distribution in a High-Risk Population |
| Q33552738 | Associations of moderate-to-vigorous-intensity physical activity and body mass index with glycated haemoglobin within the general population: a cross-sectional analysis of the 2008 Health Survey for England |
| Q35890847 | Associations of mutually exclusive categories of physical activity and sedentary time with markers of cardiometabolic health in English adults: a cross-sectional analysis of the Health Survey for England. |
| Q37613788 | Associations of objectively measured moderate-to-vigorous-intensity physical activity and sedentary time with all-cause mortality in a population of adults at high risk of type 2 diabetes mellitus |
| Q58053266 | Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health |
| Q37598304 | Associations of reallocating sitting time into standing or stepping with glucose, insulin and insulin sensitivity: a cross-sectional analysis of adults at risk of type 2 diabetes. |
| Q98474791 | Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study |
| Q58053490 | Attitudes to lifestyle risk factors for coronary heart disease amongst South Asians in Leicester: a focus group study |
| Q92664717 | Authors' Reply to Gough: "Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes" |
| Q58053270 | Authors' response |
| Q37932033 | Automated identification of miscoded and misclassified cases of diabetes from computer records |
| Q60045606 | Baby Steps - a structured group education programme with accompanying mobile web application designed to promote physical activity in women with a history of gestational diabetes: study protocol for a randomised controlled trial |
| Q36374429 | Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines |
| Q39032579 | Barriers and Facilitators to Healthy Lifestyle Changes in Minority Ethnic Populations in the UK: a Narrative Review. |
| Q38661096 | Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis |
| Q50090200 | Beyond Cut-points: Accelerometer Metrics that Capture the Physical Activity Profile |
| Q92458794 | Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes |
| Q91991197 | Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease |
| Q36988618 | Biomarker research in glucose disorders: current concepts and clinical applications |
| Q33388505 | Biomedical, lifestyle and psychosocial characteristics of people newly diagnosed with Type 2 diabetes: baseline data from the DESMOND randomized controlled trial |
| Q35552252 | Birthweight centile charts for South Asian infants born in the UK. |
| Q35978709 | Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease |
| Q35978289 | Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease |
| Q96821689 | Body mass index and risk of COVID-19 across ethnic groups: analysis of UK Biobank study |
| Q31153428 | Body mass index and waist circumference cut-points in multi-ethnic populations from the UK and India: the ADDITION-Leicester, Jaipur heart watch and New Delhi cross-sectional studies |
| Q38936371 | Breaking Up Prolonged Sitting With Standing or Walking Attenuates the Postprandial Metabolic Response in Postmenopausal Women: A Randomized Acute Study |
| Q38764063 | Breaking up sedentary time with seated upper body activity can regulate metabolic health in obese high-risk adults: A randomized crossover trial |
| Q97520241 | COVID-19 and ethnicity: A novel pathophysiological role for inflammation |
| Q96354484 | COVID-19 and ethnicity: who will research results apply to? |
| Q96684299 | COVID-19 cumulative mortality rates for frontline healthcare staff in England |
| Q98193653 | COVID-19 mortality: A complex interplay of sex, gender, and ethnicity |
| Q114119792 | COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records |
| Q104742234 | COVID-19, ethnicity and cardiometabolic disease self-management in UK primary care |
| Q101568236 | COVID-19, seasonal influenza and measles: potential triple burden and the role of flu and MMR vaccines |
| Q45992421 | Calculating the design effect for a cluster stepped-wedge trial with varying cluster size; a case study from a trial in type 2 diabetes. |
| Q45067370 | Call for consistent coding in diabetes mellitus using the Royal College of General Practitioners and NHS pragmatic classification of diabetes |
| Q97635253 | Cardiopulmonary resuscitation in primary and community care during the COVID-19 pandemic |
| Q38589500 | Cardiorespiratory fitness and risk of type 2 diabetes mellitus: A 23-year cohort study and a meta-analysis of prospective studies |
| Q96113780 | Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial |
| Q97587009 | Cardiovascular Determinants of Aerobic Exercise Capacity in Adults With Type 2 Diabetes |
| Q93232282 | Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis |
| Q91090025 | Cardiovascular efficacy and safety of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a systematic review and network meta-analysis |
| Q31143283 | Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data |
| Q102147437 | Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi-ethnic population |
| Q100476341 | Cardiovascular events and mortality in people with type 2 diabetes and multimorbidity: a real world study of patients followed up to 19 years |
| Q94667746 | Cardiovascular outcome trials of glucose-lowering therapies |
| Q95654572 | Cardiovascular risk profiles and the uptake of the NHS Healthcheck programme in male prisoners in six UK prisons: an observational cross-sectional survey |
| Q91326109 | Cardiovascular, cancer and mortality events after bariatric surgery in people with and without pre-existing diabetes: A nationwide study |
| Q57788097 | Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis |
| Q38999876 | Change in Sedentary Time, Physical Activity, Bodyweight, and HbA1c in High-Risk Adults |
| Q37660835 | Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial |
| Q64934457 | Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink. |
| Q112689900 | Characteristics of patients in platform C19, a COVID-19 research database combining primary care electronic health record and patient reported information |
| Q51435331 | Characteristics, complications and management of a large multiethnic cohort of younger adults with type 2 diabetes. |
| Q35978349 | Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease |
| Q58053509 | Chronic psoriasis and repeat admissions-do we do enough for our patients? |
| Q100516079 | Classification of aerosol-generating procedures: a rapid systematic review |
| Q51324753 | Clinical characteristics of people experiencing biochemical hypoglycaemia during an oral glucose tolerance test: cross-sectional analyses from a UK multi-ethnic population. |
| Q41138948 | Clinical characteristics of polycystic ovary syndrome: investigating differences in White and South Asian women |
| Q118732500 | Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study |
| Q34219363 | Clinical governance for diabetes in primary care: use of practice guidelines and participation in multi-practice audit |
| Q37780870 | Clinical inertia in management of T2DM. |
| Q37278100 | Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people |
| Q28067093 | Clinical inertia to insulin initiation and intensification in the UK: A focused literature review |
| Q50071151 | Clinical inertia versus overtreatment in glycaemic management |
| Q50880239 | Clinical inertia-Time to reappraise the terminology? |
| Q57058802 | Clinical management of type 2 diabetes in south Asia |
| Q90088440 | Clinical update: The important role of dual kidney function testing (ACR and eGFR) in primary care: Identification of risk and management in type 2 diabetes |
| Q30588306 | Collation and comparison of multi-practice audit data: prevalence and treatment of known diabetes mellitus |
| Q58053386 | Combined cardiovascular and diabetes risk assessment in primary care |
| Q102219701 | Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948-1957 |
| Q86259889 | Comment on Nolan et al. Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes. Diabetes 2015;64:673-686 |
| Q57734431 | Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10 |
| Q48122880 | Comment on: "Strengths and Limitations of Healthcare Databases in the Evaluation of Hypoglycaemia". |
| Q58053337 | Commentary: risk prediction models for people with Type 2 diabetes |
| Q58053422 | Community health workers for diabetes: can they help deliver improved care? |
| Q48944137 | Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides |
| Q39436177 | Comorbidities, complications and mortality in people of South Asian ethnicity with type 1 diabetes compared with other ethnic groups: a systematic review |
| Q91958312 | Comparative Relevance of Physical Fitness and Adiposity on Life Expectancy: A UK Biobank Observational Study |
| Q98227692 | Comparative effectiveness of gliclazide modified release vs sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes |
| Q46438627 | Comparison of body mass index at diagnosis of diabetes in a multi-ethnic population: A case-control study with matched non-diabetic controls |
| Q34496741 | Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus |
| Q47367638 | Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials. |
| Q57412900 | Comparison of illness representations dimensions and illness representation clusters in predicting outcomes in the first year following diagnosis of type 2 diabetes: Results from the DESMOND trial |
| Q93233974 | Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real-world studies |
| Q51748486 | Compliance of Adolescent Girls to Repeated Deployments of Wrist-worn Accelerometers. |
| Q58597960 | Conceptualising multiple drug use in patients with comorbidity and multimorbidity: proposal for standard definitions beyond the term polypharmacy |
| Q51355697 | Conduit vessel stiffness in British south Asians of Indian descent relates to 25-hydroxyvitamin D status. |
| Q44472254 | Contrasting cardiovascular risk profiles and prescribed cardio-protective therapies in newly-diagnosed type 2 diabetes identified through screening and standard practice |
| Q58053481 | Coronary heart disease in people of south-Asian origin |
| Q91300606 | Correction to: Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes |
| Q92346494 | Corrections to: Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes |
| Q92165623 | Corrigendum and Editorial Warning Regarding Use of the MMAS Scale (The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardi |
| Q57787217 | Cost-Utility of an Objective Biochemical Measure to Improve Adherence to Antihypertensive Treatment |
| Q43514338 | Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care. |
| Q89728293 | Cost-effectiveness of intensive interventions compared to standard care in individuals with type 2 diabetes: A systematic review and critical appraisal of decision-analytic models |
| Q41688351 | Coverage of a national cardiovascular risk assessment and management programme (NHS Health Check): Retrospective database study. |
| Q96639131 | Covid-19 and ethnic minorities: an urgent agenda for overdue action |
| Q91152788 | De-Intensification Of Blood Glucose Lowering Medication In People Identified As Being Over-Treated: A Mixed Methods Study |
| Q28743606 | Defining obesity cut-off points for migrant South Asians |
| Q92777751 | Deintensification in older patients with type 2 diabetes: A systematic review of approaches, rates and outcomes |
| Q35927578 | Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes |
| Q34077174 | Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. |
| Q102129872 | Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff |
| Q90002522 | Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence |
| Q44139573 | Depressive symptoms in the first year from diagnosis of Type 2 diabetes: results from the DESMOND trial |
| Q39340832 | Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective |
| Q110662217 | Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities |
| Q45844682 | Detection and potential mechanisms of subclinical left ventricular dysfunction in asymptomatic young adults with Type-2 Diabetes |
| Q34122326 | Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. |
| Q27349483 | Developing a Conceptually Equivalent Type 2 Diabetes Risk Score for Indian Gujaratis in the UK. |
| Q37353420 | Development of a lifestyle intervention using the MRC framework for diabetes prevention in people with impaired glucose regulation |
| Q100431291 | Development, content validation and reliability of the Assessment of Real World Observational Studies (ArRoWS) critical appraisal tool |
| Q98728110 | Device-measured physical activity and its association with physical function in adults with type 2 diabetes mellitus |
| Q42599551 | Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (DESMOND): process modelling of pilot study |
| Q101468740 | Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline |
| Q96431322 | Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters |
| Q44318105 | Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study |
| Q92903991 | Diabetes in adults with intellectual disability: prevalence and associated demographic, lifestyle, independence and health factors |
| Q61877290 | Diabetes in pregnancy and birth weight: differential effects due to ethnicity in a real-life observational study |
| Q55537214 | Diabetes prevalence, process of care and outcomes in relation to practice size, caseload and deprivation: national cross-sectional study in primary care. |
| Q38197970 | Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis |
| Q58053280 | Diabetes prevention: NICE opportunity for implementing programmes in the real-world setting |
| Q43044144 | Diabetes prevention: a call to action |
| Q52589573 | Diabetes research in primary care: Fiction, reality or essential? |
| Q46767611 | Diabetes screening anxiety and beliefs. |
| Q47316753 | Diabetes structured self-management education programmes: a narrative review and current innovations |
| Q39229554 | Diabetes-specific quality of life but not health status is independently associated with glycaemic control among patients with type 2 diabetes: a cross-sectional analysis of the ADDITION-Europe trial cohort |
| Q50100857 | Diabetes: Predicting severe hypoglycaemia - a step forward |
| Q33446693 | Diabetes: glycaemic control in type 2. |
| Q90779689 | Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention |
| Q36558189 | Diagnosing type 2 diabetes and identifying high-risk individuals using the new glycated haemoglobin (HbA1c) criteria |
| Q30842767 | Diagnosis of patients with chronic heart failure in primary care: usefulness of history, examination, and investigations |
| Q57934917 | Diagnostic performance of using one- or two-HbA1c cut-point strategies to detect undiagnosed type 2 diabetes and impaired glucose regulation within a multi-ethnic population |
| Q35725124 | Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on? |
| Q33588488 | Dietary habits of young people attending secondary schools serving a multiethnic, inner-city community in the UK. |
| Q35884808 | Differences in levels of physical activity between White and South Asian populations within a healthcare setting: impact of measurement type in a cross-sectional study |
| Q61445906 | Differences in objectively measured physical activity and sedentary behaviour between white Europeans and south Asians recruited from primary care: cross-sectional analysis of the PROPELS trial |
| Q36672238 | Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis |
| Q91908510 | Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes |
| Q49885114 | Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes. |
| Q36057220 | Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial |
| Q92562945 | Disparity in implantable cardioverter defibrillator therapy among minority South Asians in the United Kingdom |
| Q90831148 | Distal technology interventions in people with diabetes: an umbrella review of multiple health outcomes |
| Q36171763 | Do Web-Based Interventions Improve Well-Being in Type 2 Diabetes? A Systematic Review and Meta-Analysis |
| Q51744921 | Do sulphonylureas still have a place in clinical practice? |
| Q34114513 | Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial |
| Q36974117 | Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial |
| Q34195141 | Does self monitoring of blood glucose as opposed to urinalysis provide additional benefit in patients newly diagnosed with type 2 diabetes receiving structured education? The DESMOND SMBG randomised controlled trial protocol |
| Q99358149 | Does the presence of diabetes mellitus confer an increased risk of stroke in patients with atrial fibrillation on direct oral anticoagulants? A systematic review and meta-analysis |
| Q92544171 | Dose distribution and up-titration patterns of metformin monotherapy in patients with type 2 diabetes |
| Q99569225 | Draft FDA guidance for assessing the safety of glucose lowering therapies: a missed opportunity? |
| Q92685825 | Durability of glycaemic control in patients with type 2 diabetes after metformin failure: Prognostic model derivation and validation using the DISCOVER study |
| Q112638366 | EXTending availability of self-management structured EducatioN programmes for people with type 2 Diabetes in low-to-middle income countries (EXTEND)-a feasibility study in Mozambique and Malawi |
| Q35881450 | Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Euro |
| Q91258734 | Early Outcomes From the English National Health Service Diabetes Prevention Programme |
| Q97075296 | Early lessons from a second COVID-19 lockdown in Leicester, UK |
| Q100422665 | Editorial: Studies in young adults with type 2 diabetes to inform evidence-based guidelines specifically for early-onset type 2 diabetes are urgently required |
| Q37311311 | Educational interventions for migrant South Asians with Type 2 diabetes: a systematic review |
| Q37149020 | Educational interventions in kidney disease care: a systematic review of randomized trials |
| Q48394944 | Educational needs for blood pressure control in chronic kidney disease |
| Q91563497 | Educational weight loss interventions in obese and overweight adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials |
| Q129259541 | Effect of Conventional Lifestyle Interventions on Type 2 Diabetes Incidence by Glucose-Defined Prediabetes Phenotype: An Individual Participant Data Meta-analysis of Randomized Controlled Trials |
| Q37298754 | Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITI |
| Q35106580 | Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial |
| Q53067530 | Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study. |
| Q33621821 | Effect of insulin glargine on glycaemic control and weight in obese and non-obese people with type 2 diabetes: data from the AT.LANTUS trial |
| Q44676456 | Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes |
| Q44606929 | Effect of physical activity measurement type on the association between walking activity and glucose regulation in a high-risk population recruited from primary care. |
| Q97691576 | Effect of pragmatic versus explanatory interventions on medication adherence in people with cardiometabolic conditions: a systematic review and meta-analysis |
| Q35606921 | Effect of the PPARG2 Pro12Ala Polymorphism on Associations of Physical Activity and Sedentary Time with Markers of Insulin Sensitivity in Those with an Elevated Risk of Type 2 Diabetes |
| Q35921306 | Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care |
| Q37269496 | Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial |
| Q37979401 | Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta-analysis |
| Q34023070 | Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review. |
| Q55174630 | Effectiveness of the 'Girls Active' school-based physical activity programme: A cluster randomised controlled trial. |
| Q97880112 | Effectiveness of the Ready to Reduce Risk (3R) complex intervention for the primary prevention of cardiovascular disease: a pragmatic randomised controlled trial |
| Q104583184 | Effectiveness of the Transformation Model, a model of care that integrates diabetes services across primary, secondary and community care: A retrospective study |
| Q36482552 | Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. |
| Q90711109 | Effects of Low-Energy Diet or Exercise on Cardiovascular Function in Working-Age Adults With Type 2 Diabetes: A Prospective, Randomized, Open-Label, Blinded End Point Trial |
| Q95272113 | Effects of an Electronic Software "Prompt" With Health Care Professional Training on Cardiovascular and Renal Complications in a Multiethnic Population With Type 2 Diabetes and Microalbuminuria (the GP-Prompt Study): Results of a Pragmatic Cluster-R |
| Q91984171 | Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study |
| Q112576554 | Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries |
| Q57479891 | Effects of intensive interventions compared to standard care in people with type 2 diabetes and microalbuminuria on risk factors control and cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials |
| Q33732598 | Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program |
| Q39040946 | Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis |
| Q58576729 | Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol |
| Q89796609 | Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A systematic review and network meta-analysis |
| Q92695610 | Efficacy of low- and very-low-energy diets in people with type 2 diabetes mellitus: A systematic review and meta-analysis of interventional studies |
| Q64064437 | Eligibility of patients with type 2 diabetes for sodium-glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study |
| Q100754119 | Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes |
| Q48479640 | Empowering patients with diabetes: a qualitative primary care study focusing on South Asians in Leicester, UK. |
| Q36073820 | Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised "Let's Prevent Diabetes" Trial |
| Q91745236 | Enhancing the value of accelerometer-assessed physical activity: meaningful visual comparisons of data-driven translational accelerometer metrics |
| Q43607342 | Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease |
| Q57058805 | Epidemiology and determinants of type 2 diabetes in south Asia |
| Q30388309 | Epidemiology: The diabetes mellitus tsunami: worse than the 'Spanish flu' pandemic? |
| Q37177894 | Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK. |
| Q112691214 | Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform |
| Q58053462 | Ethnic differences in body composition in adolescents |
| Q34583331 | Ethnic differences in diabetes management in patients with and without comorbid medical conditions: a cross-sectional study |
| Q28757573 | Ethnic disparities in diabetes management and pay-for-performance in the UK: the Wandsworth Prospective Diabetes Study |
| Q104518137 | Ethnic-minority groups in England and Wales-factors associated with the size and timing of elevated COVID-19 mortality: a retrospective cohort study linking census and death records |
| Q93208172 | Ethnicity and COVID-19: an urgent public health research priority |
| Q102129684 | Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis |
| Q36416708 | Ethnicity and quality of diabetes care in a health system with universal coverage: population-based cross-sectional survey in primary care |
| Q114082025 | Ethnicity and risks of severe COVID‐19 outcomes associated with glucose‐lowering medications: a cohort study |
| Q36302068 | Evaluating tools to support a new practical classification of diabetes: excellent control may represent misdiagnosis and omission from disease registers is associated with worse control |
| Q43237046 | Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries |
| Q92180270 | Evaluation and refinement of the PRESTARt tool for identifying 12-14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study |
| Q112582318 | Evaluation of an 8-Week Vegan Diet on Plasma Trimethylamine-N-Oxide and Postchallenge Glucose in Adults with Dysglycemia or Obesity |
| Q33801750 | Evaluation of community provision of a preventive cardiovascular programme - the National Health Service Health Check in reaching the under-served groups by primary care in England: cross sectional observational study |
| Q92978308 | Evaluation of the Diabetes Screening Component of a National Cardiovascular Risk Assessment Programme in England: a Retrospective Cohort Study |
| Q44996896 | Evaluation of the Healthy LifeCheck programme: a vascular risk assessment service for community pharmacies in Leicester city, UK. |
| Q35148860 | Evaluation of the clinical and cost effectiveness of intermediate care clinics for diabetes (ICCD): a multicentre cluster randomised controlled trial |
| Q112284351 | Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain |
| Q58053325 | Evolving role of chemotherapy in castration-resistant prostate cancer |
| Q110012531 | Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries |
| Q104471140 | Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study |
| Q50579400 | Explaining engagement in self-monitoring among participants of the DESMOND Self-monitoring Trial: a qualitative interview study. |
| Q38651692 | External national validation of the Leicester Self-Assessment score for Type 2 diabetes using data from the English Longitudinal Study of Ageing |
| Q58053234 | External validation of two diabetes risk scores in a young UK South Asian population |
| Q35629844 | Feasibility of a structured group education session to improve self-management of blood pressure in people with chronic kidney disease: an open randomised pilot trial |
| Q28365479 | Features of primary care associated with variations in process and outcome of care of people with diabetes. |
| Q58053487 | Features of primary health care teams associated with successful quality improvement of diabetes care: a qualitative study |
| Q89952457 | FilterK: A new outlier detection method for k-means clustering of physical activity |
| Q58065034 | First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes |
| Q103039150 | First-line treatment for type 2 diabetes: is it too early to abandon metformin? |
| Q50595108 | Fitness Moderates Glycemic Responses to Sitting and Light Activity Breaks |
| Q48154933 | Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey |
| Q104564092 | Focused action is required to protect ethnic minority populations from COVID-19 post-lockdown |
| Q113176580 | Frameworks for implementation, uptake and use of digital health interventions in ethnic minority populations: a scoping review using cardiometabolic disease as a case study. (Preprint) |
| Q24630267 | Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis |
| Q51346564 | Fruit and vegetable intake and the association with glucose parameters: a cross-sectional analysis of the Let's Prevent Diabetes Study. |
| Q90292487 | GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice |
| Q92023736 | Genetic Discrimination Between LADA and Childhood-Onset Type 1 Diabetes Within the MHC |
| Q98730048 | Global Patterns of Comprehensive Cardiovascular Risk Factor Control in Patients with Type 2 Diabetes Mellitus: Insights from the DISCOVER Study |
| Q88538530 | Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates |
| Q91371072 | Glucose dysregulation phenotypes - time to improve outcomes |
| Q91526197 | Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting |
| Q41540308 | Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA. |
| Q93004687 | Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme |
| Q37762295 | Glycaemic goals in patients with type 2 diabetes: current status, challenges and recent advances |
| Q90568055 | Glycated Hemoglobin Level Goal Achievement in Adults With Type 2 Diabetes in Canada: Still Room for Improvement |
| Q37723756 | Has pay for performance improved the management of diabetes in the United Kingdom? |
| Q36921518 | Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries |
| Q99603624 | Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: A longitudinal cohort study |
| Q42547829 | Heart failure in primary care. |
| Q51696249 | Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. |
| Q58591597 | Hypoglycaemia is associated with increased risk of fractures in patients with type 2 diabetes mellitus: a cohort study |
| Q57412812 | Hypoglycaemia, a global cause for concern |
| Q41709013 | Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study |
| Q48155086 | Identification of barriers to insulin therapy and approaches to overcoming them |
| Q48116008 | Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography |
| Q39121355 | Identifying effective pathways in a successful continuous quality improvement programme: the GEDAPS study |
| Q44320824 | Identifying people with type 2 diabetes and those at risk: lessons from the measure your waist (MY-WAIST) mixed-methods study in UK primary care |
| Q96830772 | Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals |
| Q92533361 | Impact of Depression and Anxiety on Change to Physical Activity Following a Pragmatic Diabetes Prevention Program Within Primary Care: Pooled Analysis From Two Randomized Controlled Trials |
| Q37490913 | Impact of Information Technology-Based Interventions for Type 2 Diabetes Mellitus on Glycemic Control: A Systematic Review and Meta-Analysis |
| Q45347830 | Impact of comorbid diabetes on quality of life and perception of angina pain in people with angina registered with general practitioners in the UK. |
| Q38731435 | Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes. |
| Q43137855 | Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity. |
| Q30382697 | Impact of the National Health Service Health Check on cardiovascular disease risk: a difference-in-differences matching analysis. |
| Q31012252 | Impact of weight gain on outcomes in type 2 diabetes |
| Q51351149 | Implementation of the automated Leicester Practice Risk Score in two diabetes prevention trials provides a high yield of people with abnormal glucose tolerance. |
| Q101409657 | Improvements in Glycemic Control After Acute Moderate-Intensity Continuous or High-Intensity Interval Exercise Are Greater in South Asians Than White Europeans With Nondiabetic Hyperglycemia: A Randomized Crossover Study |
| Q93182175 | Improving quality in cardiometabolic medicine real-world evidence |
| Q43014840 | Improving the delivery of coronary care for ethnic minorities |
| Q104101234 | In-shoe pressure thresholds for people with diabetes and neuropathy at risk of ulceration: A systematic review |
| Q92184515 | Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: A UK multisite 12-month prospective observational study |
| Q91717995 | Incidence of Depression and First-Line Antidepressant Therapy in People with Obesity and Depression in Primary Care |
| Q37764077 | Incorrect and incomplete coding and classification of diabetes: a systematic review |
| Q48549470 | Increasing capacity to deliver diabetes self-management education: results of the DESMOND lay educator non-randomized controlled equivalence trial. |
| Q96024507 | Increasing uptake of structured self-management education programmes for type 2 diabetes in a primary care setting: a feasibility study |
| Q36109154 | Independent effect of ethnicity on glycemia in South Asians and white Europeans |
| Q124944410 | Individual, healthcare professional and system‐level barriers and facilitators to initiation and adherence to injectable therapies for type 2 diabetes: A systematic review and meta‐ethnography |
| Q92913008 | Individualised targets for insulin initiation in type 2 diabetes mellitus-the influence of physician and practice: a cross-sectional study in eight European countries |
| Q50130185 | Inequalities in provision of systematic care for patients with diabetes |
| Q89873458 | Influence of sociodemographic characteristics on the preferred format of health education delivery in individuals with type 2 diabetes mellitus and or cardiovascular disease: a questionnaire study |
| Q35788713 | Influences on the uptake of diabetes screening: a qualitative study in primary care |
| Q51465795 | Initiation of insulin glargine in suboptimally controlled patients with type 2 diabetes: sub-analysis of the AT.LANTUS trial comparing treatment outcomes in subjects from primary and secondary care in the UK. |
| Q37365411 | Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study |
| Q38160986 | Insulin degludec--the impact of a new basal insulin on care in type 2 diabetes |
| Q58053452 | Insulin glargine and its role in glycaemic management of Type 2 diabetes |
| Q58053302 | Insulin initiation and management in people with Type 2 diabetes in an ethnically diverse population: the healthcare provider perspective |
| Q37199318 | Insulin management in overweight or obese type 2 diabetes patients: the role of insulin glargine |
| Q31134915 | Intensity Thresholds on Raw Acceleration Data: Euclidean Norm Minus One (ENMO) and Mean Amplitude Deviation (MAD) Approaches |
| Q48592706 | Intensive multifactorial intervention improves modelled coronary heart disease risk in screen-detected Type 2 diabetes mellitus: a cluster randomized controlled trial |
| Q90307985 | Intensive versus standard multifactorial cardiovascular risk factor control in screen-detected type 2 diabetes: 5-year and longer-term modelled outcomes of the ADDITION-Leicester study |
| Q57820694 | Interventions for Improving Modifiable Risk Factor Control in the Secondary Prevention of Stroke |
| Q24194771 | Interventions for improving modifiable risk factor control in the secondary prevention of stroke |
| Q53284089 | Interventions for improving modifiable risk factor control in the secondary prevention of stroke. |
| Q95644094 | Introduction: Real-World Evidence in Type 2 Diabetes |
| Q41703043 | Inverse association between fasting plasma glucose and risk of ventricular arrhythmias |
| Q36469048 | Investigating endothelial activation and oxidative stress in relation to glycaemic control in a multiethnic population. |
| Q100419153 | Investigation of Cardiovascular Health and Risk Factors Among the Diverse and Contemporary Population in London (the TOGETHER Study): Protocol for Linking Longitudinal Medical Records |
| Q36307110 | Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study |
| Q92091222 | Is ethnicity linked to incidence or outcomes of covid-19? |
| Q45759432 | Is having a family history of type 2 diabetes or cardiovascular disease a predictive factor for metabolic syndrome? |
| Q50420044 | Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials |
| Q40231849 | Is the number of fast-food outlets in the neighbourhood related to screen-detected type 2 diabetes mellitus and associated risk factors? |
| Q31142015 | Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE study. |
| Q34576758 | Joint prevalence of diabetes, impaired glucose regulation, cardiovascular disease risk and chronic kidney disease in South Asians and White Europeans |
| Q92158275 | Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study |
| Q48099286 | Legacy benefits of blood glucose, blood pressure and lipid control in people with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia? |
| Q36200650 | Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation |
| Q42988757 | Levels of physical activity and relationship with markers of diabetes and cardiovascular disease risk in 5474 white European and South Asian adults screened for type 2 diabetes |
| Q33785308 | Liraglutide - overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes. |
| Q37874613 | Liraglutide for type 2 diabetes mellitus |
| Q100749726 | Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study |
| Q36476256 | Long terms trends of multimorbidity and association with physical activity in older English population |
| Q47562124 | Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial |
| Q91360138 | Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial |
| Q39013114 | Long-term mortality after acute myocardial infarction among individuals with and without diabetes: A systematic review and meta-analysis of studies in the post-reperfusion era. |
| Q129259533 | Low-calorie diets for people with isolated impaired fasting glucose |
| Q38376619 | Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cot |
| Q58053379 | Lower thresholds for diagnosis and management of obesity in British South Asians |
| Q93671158 | MAKING USE OF A CLINICAL AUDIT: A GUIDE TO PRACTICE IN THE HEALTH PROFESSIONS |
| Q91480783 | Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment |
| Q42547092 | Management of angina. |
| Q38791017 | Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study. |
| Q44729205 | Managing heart failure in primary care: first steps in implementing the National Service Framework |
| Q100389467 | Maturational timing, physical self-perceptions and physical activity in UK adolescent females: investigation of a mediated effects model |
| Q36120047 | Medication burden in the first 5 years following diagnosis of type 2 diabetes: findings from the ADDITION-UK trial cohort |
| Q95796382 | Meta-analysis of diabetes care in general practice. Like was not compared with like |
| Q58053477 | Metabolic syndrome |
| Q99636405 | Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme |
| Q59310899 | Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT |
| Q26783181 | Methods Used in Economic Evaluations of Chronic Kidney Disease Testing - A Systematic Review |
| Q92660782 | Micro-costing and a cost-consequence analysis of the 'Girls Active' programme: A cluster randomised controlled trial |
| Q43641154 | Miscoding, misclassification and misdiagnosis of diabetes in primary care |
| Q97901150 | Missed Opportunities for Timely Recognition of Chronic Limb-Threatening Ischaemia in Patients Undergoing a Major Amputation: A Population Based Cohort Study Using the UK's Clinical Practice Research Datalink |
| Q28219547 | Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation |
| Q91228929 | Mortality risk comparing walking pace to handgrip strength and a healthy lifestyle: A UK Biobank study |
| Q57808987 | Movement through Active Personalised engagement (MAP) - a self-management programme designed to promote physical activity in people with multimorbidity: study protocol for a randomised controlled trial |
| Q58053366 | Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: The Microalbuminuria Education and Medication Optimisation (MEMO) study |
| Q96293756 | Multimorbidity and SARS-CoV-2 infection in UK Biobank |
| Q93370221 | Multimorbidity and lifestyle factors among adults with intellectual disabilities: a cross-sectional analysis of a UK cohort |
| Q102212172 | NHS Health Check Programme: a qualitative study of prison experience |
| Q58053467 | Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfaction |
| Q42906379 | Near-patient testing in primary care |
| Q50766975 | New cases of diabetes mellitus in England and Wales, 1994-1998: database study |
| Q50207041 | New drug treatments versus structured education programmes for type 2 diabetes: comparing cost-effectiveness |
| Q37516952 | New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes |
| Q96340815 | New-Onset Diabetes in Covid-19 |
| Q104582080 | No cases of asymptomatic SARS-CoV-2 infection among healthcare staff in a city under lockdown restrictions: lessons to inform 'Operation Moonshot' |
| Q40180586 | Nonexercise Equations to Estimate Fitness in White European and South Asian Men. |
| Q39020343 | Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies |
| Q94557812 | Number needed to treat in cardiovascular outcome trials with glucagon-like peptide-1 receptor agonists: A systematic review with temporal analysis |
| Q43048218 | Obesity and chronic disease in younger people: an unfolding crisis. |
| Q46547756 | Obesity and intermediate clinical outcomes in diabetes: evidence of a differential relationship across ethnic groups |
| Q96129637 | Obesity and risk of COVID-19: analysis of UK biobank |
| Q43553202 | Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease |
| Q64120468 | Objective measures of non-adherence in cardiometabolic diseases: a review focused on urine biochemical screening |
| Q41031042 | Objectively measured sedentary time and associations with insulin sensitivity: Importance of reallocating sedentary time to physical activity |
| Q91067879 | Online patient education interventions in type 2 diabetes or cardiovascular disease: A systematic review of systematic reviews |
| Q30248920 | Optimizing management of glycaemia |
| Q35806871 | PRomotion Of Physical activity through structured Education with differing Levels of ongoing Support for people at high risk of type 2 diabetes (PROPELS): study protocol for a randomized controlled trial. |
| Q100453438 | Pandemic threatens primary care for long term conditions |
| Q37802321 | Patient safety systems in the primary health care of diabetes—a story of missed opportunities? |
| Q88865552 | Patterns of Multimorbidity in Middle-Aged and Older Adults: An Analysis of the UK Biobank Data |
| Q38620148 | Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany. |
| Q90406667 | Perceptions of healthcare professionals and people with type 2 diabetes on emotional support: a qualitative study |
| Q53563566 | Pharmaceutical Interventions for Diabetes Prevention in Patients at Risk. |
| Q30829257 | Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis |
| Q104267742 | Pharmacological management of South Asians with Type 2 Diabetes: Consensus Recommendations from the South Asian Health Foundation |
| Q57032375 | Physical Activity after Cardiac EventS (PACES) - a group education programme with subsequent text-message support designed to increase physical activity in individuals with diagnosed coronary heart disease: study protocol for a randomised controlled |
| Q90757082 | Physical activity and lipidomics in a population at high risk of type 2 diabetes mellitus |
| Q39797337 | Physical activity and sedentary behaviours of South Asian and white European children in inner city secondary schools in the UK. |
| Q64908035 | Physical activity, multimorbidity, and life expectancy: a UK Biobank longitudinal study. |
| Q89023339 | Polycystic ovary syndrome: An underestimated problem in primary care |
| Q90743995 | Postpartum monitoring of women with a history of gestational diabetes - A cross-sectional study of an inner-city population |
| Q37731636 | Practical guidance to insulin management |
| Q93227089 | Practical recommendations for the management of diabetes in patients with COVID-19 |
| Q89535068 | Pragmatic management of low-energy diets in people with type 2 diabetes in primary care: a decision aid for clinicians |
| Q33653750 | Predicting hospital stay, mortality and readmission in people admitted for hypoglycaemia: prognostic models derivation and validation |
| Q90605456 | Prediction of Diabetic Foot Ulceration: The Value of Using Microclimate Sensor Arrays |
| Q100962124 | Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data |
| Q92372534 | Predictors of the Acute Postprandial Response to Breaking Up Prolonged Sitting |
| Q38056518 | Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception |
| Q28084768 | Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies |
| Q45087797 | Prevalence and characteristics in coding, classification and diagnosis of diabetes in primary care |
| Q53681767 | Prevalence and incidence of complications at diagnosis of T2DM and during follow-up by BMI and ethnicity: a matched case-control analysis. |
| Q58578888 | Prevalence and progression of diabetic nephropathy in South Asians, White Europeans and Afro-Caribbeans with Type 2 diabetes; a systematic review and meta-analysis |
| Q96646219 | Prevalence of comorbidities and their association with mortality in patients with COVID-19: A Systematic Review and Meta-analysis |
| Q51261559 | Prevalence of diabetes and impaired glucose metabolism in younger 'at risk' UK adults: insights from the STAND programme of research. |
| Q51632566 | Prevalence of diagnosed depression in South Asian and white European people with type 1 and type 2 diabetes mellitus in a UK secondary care population. |
| Q38338888 | Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions |
| Q37592948 | Preventing type 2 diabetes: can we make the evidence work? |
| Q58053430 | Preventing type 2 diabetes: making the evidence work for migrant Indian populations |
| Q33812587 | Prevention and cure of type 2 diabetes. General practitioners are treating more cases of diabetes |
| Q35747962 | Prevention of Type 2 diabetes mellitus. A review of the evidence and its application in a UK setting. |
| Q58053465 | Prevention of diabetes: A reality in primary care? |
| Q55172935 | Primary prevention of cardiovascular disease using validated risk scores: a systematic review. |
| Q37018339 | Primary prevention of type-2 diabetes and heart disease: action research in secondary schools serving an ethnically diverse UK population. |
| Q89685823 | Priorities of patients with multimorbidity and of clinicians regarding treatment and health outcomes: a systematic mixed studies review |
| Q92977203 | Process evaluation of the school-based Girls Active programme |
| Q46545188 | Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis |
| Q94669563 | Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis |
| Q91120152 | Prospectively Reallocating Sedentary Time: Associations with Cardiometabolic Health |
| Q58053508 | Psoriasis, nails, joints and autoimmunity |
| Q40207740 | Psychological morbidity and illness appraisals of patients with cardiac and non-cardiac chest pain attending a rapid access chest pain clinic: a longitudinal cohort study |
| Q57058800 | Public health and health systems: implications for the prevention and management of type 2 diabetes in south Asia |
| Q91982392 | Qualitative evaluation of A Safer Ramadan, a structured education programme that addresses the safer observance of Ramadan for Muslims with Type 2 diabetes |
| Q41628330 | Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry®. |
| Q37106404 | Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study |
| Q43063235 | Quality of clinical care in general practice |
| Q36986188 | Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes |
| Q45142675 | Quality of secondary prevention measures in TIA patients: a retrospective cohort study |
| Q35800964 | Randomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus. |
| Q88142916 | Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study |
| Q91258808 | Rationale and design of a cross-sectional study to investigate and describe the chronotype of patients with type 2 diabetes and the effect on glycaemic control: the CODEC study |
| Q33737219 | Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening |
| Q34094570 | Rationale and study design for a randomised controlled trial to reduce sedentary time in adults at risk of type 2 diabetes mellitus: project stand (Sedentary Time ANd diabetes) |
| Q31165035 | Rationale, design and baseline data from the Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: a randomized controlled trial |
| Q64099651 | Rationale, design and study protocol of the randomised controlled trial: Diabetes Interventional Assessment of Slimming or Training tO Lessen Inconspicuous Cardiovascular Dysfunction (the DIASTOLIC study) |
| Q31096351 | Raw Accelerometer Data Analysis with GGIR R-package: Does Accelerometer Brand Matter? |
| Q59236264 | Reaction time, cardiorespiratory fitness and mortality in UK Biobank: An observational study |
| Q38074481 | Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review |
| Q46348934 | Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project |
| Q47330495 | Reallocating sitting time to standing or stepping through isotemporal analysis: associations with markers of chronic low-grade inflammation |
| Q37328847 | Recent advances in the management of type 2 diabetes mellitus: a review. |
| Q94518809 | Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus |
| Q36249898 | Reducing sedentary time in adults at risk of type 2 diabetes: process evaluation of the STAND (Sedentary Time ANd Diabetes) RCT. |
| Q101216545 | Reducing vitamin D requests in a primary care cohort: a quality improvement study |
| Q35509007 | Referral for autopsies: analysis of 651 consecutive deaths in one general practice. |
| Q88575552 | Regional variations in definitions and rates of hypoglycaemia: findings from the global HAT observational study of 27 585 people with Type 1 and insulin-treated Type 2 diabetes mellitus |
| Q28071668 | Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis |
| Q92386141 | Relevance of physical function in the association of red and processed meat intake with all-cause, cardiovascular, and cancer mortality |
| Q90920135 | Reply to Mantovani: "Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes" |
| Q95802647 | Requesting necropsies. General practitioners should be taught relevant skills during vocational training |
| Q52684472 | Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of |
| Q58053236 | Response to Comment on Khunti et al. Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More Than 80,000 People. Diabetes Care 2013;36:3411–3417 |
| Q92736493 | Response to commentary by Rhew and colleagues on: Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence |
| Q98209572 | Response to letter to the editor by Abhipsha Sur Roy and Amol Joshi regarding the article: 'Multimorbidity and SARS-CoV-2 infection in UK Biobank' (Chudasama et al.). |
| Q44625410 | Results from the UK cohort of SOLVE: providing insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice |
| Q89720296 | Risk Factors for Heart Failure: 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity |
| Q112690343 | Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients |
| Q38201571 | Risk assessment tools for detecting those with pre-diabetes: a systematic review |
| Q47948836 | Risk factors and outcome differences in hypoglycaemia-related hospital admissions: A case-control study in England |
| Q98474789 | Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study |
| Q58053345 | Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance |
| Q124129372 | Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study |
| Q114066679 | Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex |
| Q102323491 | Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts |
| Q37460057 | Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. |
| Q117336371 | Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England |
| Q92956760 | Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial |
| Q95644096 | Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives |
| Q88936215 | SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL |
| Q50421805 | SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-analysis |
| Q27331464 | STEPWISE - STructured lifestyle Education for People WIth SchizophrEnia: a study protocol for a randomised controlled trial |
| Q51372498 | Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. |
| Q95357532 | Screening for glucose intolerance and development of a lifestyle education programme for prevention of type 2 diabetes in a population with intellectual disabilities: the STOP Diabetes research project |
| Q43174799 | Screening for the metabolic syndrome using simple anthropometric measurements in south Asian and white Europeans: a population-based screening study. The Leicester Ethnic Atherosclerosis and Diabetes Risk (LEADER) Study. |
| Q34187545 | Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study |
| Q44288050 | Screening for type 2 diabetes. Lessons from the ADDITION-Europe study |
| Q38070967 | Screening, evaluation and management of depression in people with diabetes in primary care |
| Q37634601 | Searching for the right outcome? A systematic review and meta-analysis of controlled trials using carotid intima-media thickness or pulse wave velocity to infer antiatherogenic properties of thiazolidinediones |
| Q58053376 | Sedentary Behavior |
| Q40332093 | Sedentary Sphere: Wrist-Worn Accelerometer-Brand Independent Posture Classification |
| Q48370165 | Sedentary Time and MRI-Derived Measures of Adiposity in Active Versus Inactive Individuals |
| Q28534691 | Sedentary time and markers of chronic low-grade inflammation in a high risk population |
| Q34293900 | Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis |
| Q92491799 | Self-Compassion, Metabolic Control and Health Status in Individuals with Type 2 Diabetes: A UK Observational Study |
| Q38690477 | Self-knowledge of HbA1c in people with Type 2 Diabetes Mellitus and its association with glycaemic control |
| Q43954988 | Self-reported sitting time and markers of inflammation, insulin resistance, and adiposity |
| Q38068629 | Self-titration of insulin in the management of people with type 2 diabetes: a practical solution to improve management in primary care |
| Q41474788 | Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence. |
| Q94601690 | Serum albumin, cardiometabolic and other adverse outcomes: systematic review and meta-analyses of 48 published observational cohort studies involving 1,492,237 participants |
| Q35324633 | Serum potassium and glucose regulation in the ADDITION-Leicester screening study |
| Q98165524 | Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study |
| Q44569165 | Severe hypoglycaemia requiring emergency medical assistance by ambulance services in the East Midlands: a retrospective study. |
| Q57274525 | Shared Care Guidelines and Protocols in the United Kingdom |
| Q89388288 | Shared decision making in multimorbidity |
| Q37801208 | Should glycated haemoglobin (HbA1c) be used to detect people with type 2 diabetes mellitus and impaired glucose regulation? |
| Q59310890 | Should sodium-glucose co-transporter-2 inhibitors be considered as first-line oral therapy for people with type 2 diabetes? |
| Q58053348 | Should we screen for type 2 diabetes: Yes |
| Q90917016 | Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study |
| Q39112468 | Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations |
| Q98718644 | Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: Results from an observational cohort study |
| Q96343098 | Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: the DISCOVER study |
| Q48114481 | Sodium-glucose co-transporter-2 inhibitors and cardiovascular outcome studies in people with type 2 diabetes: From efficacy to effectiveness |
| Q34127221 | South Asian individuals at high risk of type 2 diabetes have lower plasma vitamin C levels than white Europeans |
| Q59162742 | Stability Of Self-reported And Objectively Assessed Physical Activity Over A 3 Year Period In Comparison To Bmi |
| Q39198236 | Stability and predictive utility, over 3 years, of the illness beliefs of individuals recently diagnosed with Type 2 diabetes mellitus. |
| Q39758838 | Stand up for your health: Is it time to rethink the physical activity paradigm? |
| Q91576332 | Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients |
| Q36250146 | Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis |
| Q92428802 | Statins and risk of thromboembolism: A meta-regression to disentangle the efficacy-to-effectiveness gap using observational and trial evidence |
| Q39215531 | Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies |
| Q36738241 | Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. |
| Q24234380 | Stroke services for risk reduction in the secondary prevention of stroke |
| Q47157202 | Structured education programme for women with polycystic ovary syndrome: a randomised controlled trial |
| Q57268682 | Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial |
| Q59361925 | Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCT |
| Q46408595 | Study design and protocol for a mixed methods evaluation of an intervention to reduce and break up sitting time in primary school classrooms in the UK: The CLASS PAL (Physically Active Learning) Programme. |
| Q58053312 | Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice |
| Q52839379 | Subclinical diastolic dysfunction in young adults with Type 2 diabetes mellitus: a multiparametric contrast-enhanced cardiovascular magnetic resonance pilot study assessing potential mechanisms. |
| Q86711439 | Survival in South Asian and White European patients after acute myocardial infarction |
| Q26795627 | Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes |
| Q30482633 | Systematic review of open access echocardiography for primary care |
| Q58053262 | Systematic review of the development, implementation and availability of smart-phone applications for assessing Type 2 diabetes risk |
| Q97550121 | TEMPORARY REMOVAL: Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: Evidence-based advances in monitoring and treatment |
| Q59162743 | Tapping The Potential Presented By The Gravity Component Of An Accelerometer Signal |
| Q50139478 | Technology and chronic disease management - Authors' reply |
| Q96950062 | Temporal Trend in Young-Onset Type 2 Diabetes-the Macrovascular and Mortality Risk: Study of U.K. Primary Care Electronic Medical Records |
| Q92809723 | Temporal variation of renal function in people with type 2 diabetes mellitus: A retrospective UK clinical practice research datalink cohort study |
| Q52806347 | The Berlin Declaration: A call to action to improve early actions related to type 2 diabetes. How can specialist care help? |
| Q53819329 | The Berlin Declaration: A call to improve early actions related to type 2 diabetes. Why is primary care important? |
| Q57412984 | The DESMOND educational intervention |
| Q91622025 | The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting |
| Q51888375 | The EUCCLID study: proposed European study on care and complications in people with type 2 diabetes in primary care. |
| Q35677315 | The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis |
| Q39920188 | The European EUCCLID pilot study on care and complications in an unselected sample of people with type 2 diabetes in primary care |
| Q59310906 | The General Practitioner Prompt Study to Reduce Cardiovascular and Renal Complications in Patients With Type 2 Diabetes and Renal Complications: Protocol and Baseline Characteristics for a Cluster Randomized Controlled Trial (Preprint) |
| Q55354364 | The General Practitioner Prompt Study to Reduce Cardiovascular and Renal Complications in Patients With Type 2 Diabetes and Renal Complications: Protocol and Baseline Characteristics for a Cluster Randomized Controlled Trial. |
| Q42960862 | The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting |
| Q90031665 | The Microalbuminuria Education Medication and Optimisation (MEMO) study: 4 years follow-up of multifactorial intervention in high-risk individuals with type 2 diabetes |
| Q37429475 | The National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Leicestershire, Northamptonshire and Rutland (LNR): a programme protocol |
| Q58053362 | The Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at 2 years? |
| Q59310892 | The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled Trial |
| Q59310895 | The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled Trial (Prepr |
| Q33889954 | The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data |
| Q38835927 | The association between air pollution and type 2 diabetes in a large cross-sectional study in Leicester: The CHAMPIONS Study. |
| Q50624199 | The association between anxiety and measures of glycaemia in a population-based diabetes screening programme |
| Q43699627 | The association between body mass index and health-related quality of life: influence of ethnicity on this relationship |
| Q37699103 | The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review |
| Q47159698 | The association between depressive symptoms and insulin resistance, inflammation and adiposity in men and women |
| Q28649380 | The association between neighbourhood greenspace and type 2 diabetes in a large cross-sectional study |
| Q34515956 | The association of the triglyceride-to-HDL cholesterol ratio with insulin resistance in White European and South Asian men and women |
| Q95591280 | The authors reply |
| Q40969339 | The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study |
| Q45399327 | The development and validation of the Portuguese risk score for detecting type 2 diabetes and impaired fasting glucose. |
| Q37502281 | The eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease--prospective longitudinal study in a multiet |
| Q91230971 | The effect of Ramadan fasting on cardiovascular events and risk factors in patients with type 2 diabetes: A systematic review |
| Q38130529 | The effect of antiobesity drugs on waist circumference: a mixed treatment comparison |
| Q42857339 | The effect of increased ambulatory activity on markers of chronic low-grade inflammation: evidence from the PREPARE programme randomized controlled trial |
| Q35137431 | The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting |
| Q97526206 | The efficacy of PPE for COVID-19-type respiratory illnesses in primary and community care staff |
| Q99545408 | The impact of Covid-19 and lockdown measures on self-reported life satisfaction and social relationships does not differ by ethnicity |
| Q40219866 | The impact of a programme to improve quality of care for people with type 2 diabetes on hard to reach groups: The GEDAPS study |
| Q91169667 | The impact of an intervention to increase uptake to structured self-management education for people with type 2 diabetes mellitus in primary care (the embedding package), compared to usual care, on glycaemic control: study protocol for a mixed metho |
| Q38077649 | The impact of diet and lifestyle management strategies for obstructive sleep apnoea in adults: a systematic review and meta-analysis of randomised controlled trials |
| Q97426865 | The impact of ethnicity on clinical outcomes in COVID-19: A systematic review |
| Q99240566 | The impact of obesity on severe disease and mortality in people with SARS-CoV-2: A systematic review and meta-analysis |
| Q92180237 | The importance of the initial period of basal insulin titration in people with diabetes |
| Q91265950 | The increased risk of microvascular complications in South Asians with type 1 diabetes is influenced by migration |
| Q42656667 | The interdisciplinary team in type 2 diabetes management: Challenges and best practice solutions from real-world scenarios. |
| Q102335346 | The language of ethnicity |
| Q90079890 | The multimorbidity epidemic: challenges for real-world research |
| Q42969195 | The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort |
| Q42968141 | The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus. |
| Q91589181 | The present and future scope of real-world evidence research in diabetes: What questions can and cannot be answered and what might be possible in the future? |
| Q33515586 | The prevalence of depression in white-European and South-Asian people with impaired glucose regulation and screen-detected type 2 diabetes mellitus. |
| Q42960860 | The prevalence of depressive symptoms in a white European and South Asian population with impaired glucose regulation and screen-detected Type 2 diabetes mellitus: a comparison of two screening tools. |
| Q38629235 | The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis |
| Q93075282 | The right place for Sulphonylureas today |
| Q35799790 | The role of physical activity in the management of impaired glucose tolerance: a systematic review |
| Q37436675 | The role of physical activity in the management of type 2 diabetes mellitus |
| Q46377272 | The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries |
| Q26744317 | The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies |
| Q59162747 | The ‘Girls Active’ Physical Activity Intervention |
| Q91759978 | Therapeutic Inertia and the Legacy of Dysglycemia on the Microvascular and Macrovascular Complications of Diabetes |
| Q49380812 | Therapeutic inertia amongst general practitioners with interest in diabetes |
| Q47716792 | Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment. |
| Q38611795 | Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review |
| Q64069458 | Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia |
| Q92139671 | Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) |
| Q91068483 | Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes |
| Q104072091 | Toe gaps and their assessment in footwear for people with diabetes: a narrative review |
| Q90802312 | Towards a Portable Model to Discriminate Activity Clusters from Accelerometer Data |
| Q38684448 | Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program |
| Q92574488 | Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study |
| Q91818252 | Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme |
| Q91605452 | Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017 |
| Q57274516 | Trends in cardiovascular admissions and procedures for people with and without diabetes in England, 1996–2005 |
| Q39689507 | Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study |
| Q38252921 | Trends in the prevalence of type 2 diabetes mellitus and obesity in the Arabian Gulf States: systematic review and meta-analysis |
| Q89258111 | Type 2 diabetes |
| Q88272504 | Type 2 diabetes - Authors' reply |
| Q30394109 | Type 2 diabetes and cardiovascular disease in South Asians |
| Q43920599 | Type 2 diabetes in younger adults: clinical characteristics, diabetes-related complications and management of risk factors |
| Q37802133 | Type 2 diabetes in younger adults: the emerging UK epidemic. |
| Q58053253 | Type 2 diabetes risk prediction—Do biomarkers increase detection? |
| Q92873231 | Type 2 diabetes treatment and outcomes worldwide: A short review of the DISCOVER study programme |
| Q86712027 | Type 2 diabetes: lifetime risk of advancing from prediabetes |
| Q39236292 | Type 2 diabetes mellitus and obesity in young adults: the extreme phenotype with early cardiovascular dysfunction. |
| Q58053394 | Unanswered questions over NHS health checks |
| Q39551189 | Under-representation of minority ethnic groups in cardiovascular research: a semi-structured interview study |
| Q33904237 | Understanding and supporting women with polycystic ovary syndrome: a qualitative study in an ethnically diverse UK sample |
| Q61806676 | Update on the General Practice Optimising Structured Monitoring to Improve Clinical Outcomes in Type 2 Diabetes (GP-OSMOTIC) trial: statistical analysis plan for a multi-centre randomised controlled trial |
| Q104494782 | Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes |
| Q104067007 | Use of MyDesmond digital education programme to support self-management in people with type 2 diabetes during the COVID-19 pandemic |
| Q33759143 | Use of multiple methods to determine factors affecting quality of care of patients with diabetes. |
| Q92158268 | Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial |
| Q90595163 | Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes |
| Q94550171 | Using Intervention Mapping to Develop a Digital Self-Management Program for People With Type 2 Diabetes: Tutorial on MyDESMOND |
| Q50583348 | Using an interactive DVD about type 2 diabetes and insulin therapy in a UK South Asian community and in patient education and healthcare provider training |
| Q37609576 | Using surrogate markers in primary electronic patient record systems to confirm or refute the diagnosis of diabetes. |
| Q54684979 | Validity of self-assessed waist circumference in a multi-ethnic UK population. |
| Q43187562 | Value of ECGs in identifying heart failure due to left ventricular systolic dysfunction. Courses on interpreting ECGs would improve general practitioners' skills |
| Q113780443 | Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies |
| Q33508946 | Variation in the recording of diabetes diagnostic data in primary care computer systems: implications for the quality of care. |
| Q59804179 | Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program) |
| Q58053434 | Vascular risk checks in the UK: strategic challenges for implementation |
| Q45933640 | Waist circumference measurement: knowledge, attitudes and barriers in patients and practitioners in a multi-ethnic population. |
| Q46681729 | Waiting for diabetes: perceptions of people with pre-diabetes: a qualitative study. |
| Q46464193 | Walking and inflammatory markers in individuals screened for type 2 diabetes |
| Q34285191 | Walking away from type 2 diabetes: trial protocol of a cluster randomised controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes |
| Q91169361 | Walking pace improves all-cause and cardiovascular mortality risk prediction: A UK Biobank prognostic study |
| Q37928829 | Weight beneficial treatments for type 2 diabetes |
| Q54964140 | Weight loss and mortality risk in patients with different adiposity at diagnosis of type 2 diabetes: a longitudinal cohort study. |
| Q38682071 | What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries |
| Q48175195 | What have we learnt from "real world" data, observational studies and meta-analyses |
| Q34160789 | What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review |
| Q95841183 | What is the optimal blood pressure level for patients with atrial fibrillation treated with direct oral anticoagulants? |
| Q103824157 | Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes? |
| Q101127693 | Who should be prioritised for COVID-19 vaccines? |
| Q98621638 | Will oral semaglutide be a game-changer in the management of type 2 diabetes in primary care? |
| Q57274484 | Women develop type 2 diabetes at a higher body mass index than men |
| Q94598489 | Zinc-alpha2-glycoprotein, dysglycaemia and insulin resistance: a systematic review and meta-analysis |
| Q93071576 | activPAL and ActiGraph Assessed Sedentary Behavior and Cardiometabolic Health Markers |
| Kamlesh Khunti | wikipedia |
Search more.